Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China
· Delayed Price · Currency is CNY 15.78
-0.42 (-2.59%)
Apr 30, 2025, 3:00 PM CST
SHA:603858 Revenue
Shandong Buchang Pharmaceuticals had revenue of 2.78B CNY in the quarter ending March 31, 2025, a decrease of -14.62%. This brings the company's revenue in the last twelve months to 11.78B, down -13.60% year-over-year. In the year 2023, Shandong Buchang Pharmaceuticals had annual revenue of 13.25B, down -11.41%.
Revenue (ttm)
11.78B
Revenue Growth
-13.60%
P/S Ratio
1.43
Revenue / Employee
1.42M
Employees
8,311
Market Cap
16.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 13.25B | -1.71B | -11.41% |
| Dec 31, 2022 | 14.95B | -811.43M | -5.15% |
| Dec 31, 2021 | 15.76B | -244.03M | -1.52% |
| Dec 31, 2020 | 16.01B | 1.75B | 12.28% |
| Dec 31, 2019 | 14.26B | 590.70M | 4.32% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |